Valuation : Novartis AG

Market Cap 262B 225B 212B 193B 362B 24,925B 363B 2,515B 972B 12,698B 984B 962B 40,228B P/E 2026 *
19.5x
P/E 2027 * 16.6x
Enterprise Value 294B 253B 238B 217B 405B 27,930B 407B 2,819B 1,089B 14,229B 1,102B 1,078B 45,079B EV / Sales 2026 *
5.09x
EV / Sales 2027 * 4.73x
Free-Float
91.66%
Yield 2026 *
3.2%
Yield 2027 * 3.34%
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 262B
+0.03%-3.09%+49.77%+91.69% 1,002B
-0.76%-2.95%+50.93%+66.34% 644B
+0.86%-4.13%+19.24%+68.37% 443B
-0.56%-3.11%+29.80%+36.04% 343B
+1.10%-14.18%+11.87%+27.62% 262B
+0.09%-4.35%-2.48%+10.63% 245B
-0.48%-11.65%+39.75%+50.82% 212B
-0.11%-4.28%-17.80%-57.79% 199B
-0.68%-2.65%+25.82%+91.64% 181B
Average +0.30%-5.00%+22.99%+42.82% 392.19B
Weighted average by Cap. +0.57%-4.24%+32.14%+57.49%

Financials

2026 *2027 *
Net sales 57.64B 49.6B 46.7B 42.55B 79.62B 5,485B 79.93B 554B 214B 2,794B 216B 212B 8,852B 61.32B 52.77B 49.68B 45.27B 84.7B 5,835B 85.04B 589B 228B 2,973B 230B 225B 9,417B
Net income 14.19B 12.21B 11.5B 10.48B 19.6B 1,350B 19.68B 136B 52.67B 688B 53.29B 52.13B 2,179B 15.75B 13.55B 12.76B 11.63B 21.75B 1,498B 21.84B 151B 58.45B 763B 59.13B 57.85B 2,418B
Net Debt 31.58B 27.18B 25.59B 23.32B 43.63B 3,005B 43.8B 303B 117B 1,531B 119B 116B 4,851B 27.9B 24B 22.6B 20.59B 38.53B 2,654B 38.69B 268B 104B 1,352B 105B 102B 4,284B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
137.81USD
Average target price
154.17USD
Spread / Average Target
+11.87%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!